Notably, the substantial lack of expression of HLA-G in normal tissues, associated with its presence on tumor cells, makes HLA-G an ideal tumor-specific target to be used also for chimeric antigen receptor (CAR) development [63]. This evidence concerns the gene HLA-G and neoplasm.